Figure 4
Changes in urinary protein-to-creatinine ratio (UPCR) and relationship between blood pressure (BP) reduction and the reduction in UPCR. (a) Mean changes in the UPCR (g g−1 Cr) from baseline to 6 and 12 months in the losartan (LS) group (open column) and the LS/hydrochlorothiazide (HCTZ) group (closed column) are shown. *P<0.05 vs. the LS group. (b) The relationship between systolic blood pressure (SBP) reduction (ΔSBP) and the reduction in UPCR (ΔUPCR) from baseline to 12 months was not significant. (c) The relationship between diastolic blood pressure (DBP) reduction (ΔDBP) and the reduction in UPCR (ΔUPCR) from baseline to 12 months was not significant. Open square, the LS group; closed circle, the LS/HCTZ group.
